Northwestern Mutual Wealth Management’s ANI Pharmaceuticals ANIP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.08K	Sell	40 -30	-43%	-$2.34K	﹤0.01%	3465
2025 Q4	$5.53K	Buy	70 +30	+75%	+$2.6K	﹤0.01%	3195
2025 Q3	$3.66K	Hold	40	–	–	﹤0.01%	3243
2025 Q2	$2.61K	Hold	40	–	–	﹤0.01%	3189
2025 Q1	$2.68K	Hold	40	–	–	﹤0.01%	3082
2024 Q4	$2.21K	Hold	40	–	–	﹤0.01%	3153
2024 Q3	$2.39K	Buy	+40	New	+$2.44K	﹤0.01%	3084
2024 Q1	–	Sell	-8,500	Closed	-$469K	–	3567
2023 Q4	$469K	Buy	8,500 +8,382	+7,103%	+$462K	﹤0.01%	1232
2023 Q3	$6.85K	Buy	+118	New	+$6.81K	﹤0.01%	2657
2022 Q3	–	Sell	-1	Closed	–	–	3099
2022 Q2	$0	Buy	+1	New	+$29	﹤0.01%	3159
2018 Q1	–	Sell	-33	Closed	-$2K	–	2182
2017 Q4	$2K	Buy	+33	New	+$2.05K	﹤0.01%	2062
2017 Q1	–	Sell	-113	Closed	-$7K	–	2005
2016 Q4	$7K	Buy	+113	New	+$6.91K	﹤0.01%	1722
2016 Q3	–	Sell	-62	Closed	-$3K	–	250
2016 Q2	$3K	Hold	62	–	–	﹤0.01%	1728
2016 Q1	$2K	Buy	+62	New	+$2.1K	﹤0.01%	1862

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northwestern Mutual Wealth Management's ANIP Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its ANI Pharmaceuticals (ANIP) stake by 43% in Q1 2026, selling an estimated $2.34K and leaving 40 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3465.

Northwestern Mutual Wealth Management first reported a position in ANIP in Q1 2016 and has held it in 14 quarters since. The position peaked at $469K in Q4 2023. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

Northwestern Mutual Wealth Management held 40 shares of ANI Pharmaceuticals worth $3.08K as of Q1 2026.
Northwestern Mutual Wealth Management sold 30 ANI Pharmaceuticals shares in Q1 2026, an estimated $2.34K.
ANI Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3465 holding.
Northwestern Mutual Wealth Management first reported a position in ANI Pharmaceuticals in Q1 2016 and has held it in 14 quarters since.
Northwestern Mutual Wealth Management's ANI Pharmaceuticals position peaked at $469K in Q4 2023.
280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.